In patients on newly prescribed donepezil, the primary reason for discontinuation was an adverse event. Cognitive assessments revealed no significant worsening at 1 year, indicating that continuous donepezil treatment contributes to the maintenance of cognitive function.
Authors: Kee Hyung Park, YoungSoon Yang, Christopher Chen, Yong S. Shim, Jacqueline C. Dominguez, Chan‐Nyoung Lee, Kyunghun Kang, Han Jo Kim, Seul‐Ki Jeong, Jee Hyang Jeong, Zhen Hong, Soo Jin Yoon, Zhenxin Zhang, Eun‐Joo Kim, Jae‐Won Jang, Yansheng Li, Yun Xu, Yu‐Te Lin, Qiumin Qu, Chaur‐Jong Hu, Chih‐Ho Chou, Dongsheng Fan, Nagaendran Kandiah, Yuan‐Han Yang, Chi Ieong Lau, Leung‐Wing Chu, Huali Wang, San Jung, Seong Hye Choi, SangYun Kim
DOI: https://doi.org/10.3988/jcn.2021.17.3.376
Publish Year: 2021
